{"transactions":[{"id":4638781,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-10-09T21:05:05.000Z","date":"2026-10-07","kind":"sale","planned":false,"acquired":false,"shares":1327,"price":32.06,"value":42543.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 50,787 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 3,174 of these RSUs vested on October 1, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.58 - $32.30 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":175218,"source":{"system":"sec-edgar","filing":"0001779707-26-000009","document":"wk-form4_1791579901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779707/000177970726000009/wk-form4_1791579901.xml","form_type":"4"}},{"id":4626913,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:05:33.000Z","date":"2026-09-23","kind":"sale","planned":false,"acquired":false,"shares":2846,"price":36.36,"value":103480.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on December 18, 2024, of which 6,872 of these RSUs vested on\nSeptember 16, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The\nsale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.35 - $36.66 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":176545,"source":{"system":"sec-edgar","filing":"0001764013-26-000108","document":"wk-form4_1790366730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779707/000176401326000108/wk-form4_1790366730.xml","form_type":"4"}},{"id":711212,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-10T20:13:43.000Z","date":"2026-07-08","kind":"sale","planned":false,"acquired":false,"shares":63,"price":39.99,"value":2519.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 50,787 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 3,174 of these RSUs vested on July 1, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 - $40.03 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":179391,"source":{"system":"sec-edgar","filing":"0001764013-26-000082","document":"wk-form4_1783714421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000082/wk-form4_1783714421.xml","form_type":"4"}},{"id":711211,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-10T20:13:43.000Z","date":"2026-07-08","kind":"sale","planned":false,"acquired":false,"shares":1143,"price":39.53,"value":45182.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 50,787 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 3,174 of these RSUs vested on July 1, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.91 - $39.89 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":179454,"source":{"system":"sec-edgar","filing":"0001764013-26-000082","document":"wk-form4_1783714421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000082/wk-form4_1783714421.xml","form_type":"4"}},{"id":725545,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T23:45:00.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":false,"shares":17824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award of stock options to purchase Common Shares with a grant date of April 1, 2025. The shares underlying the option vest as to 25% on April 1, 2026, with the remainder vesting in 36 successive substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continued service to the Issuer as of such date."}],"balance_after":53707,"derivative":{"exercise_price":15.2,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":17824},"source":{"system":"sec-edgar","filing":"0001764013-26-000073","document":"wk-form4_1782517498.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000073/wk-form4_1782517498.xml","form_type":"4"}},{"id":725544,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:45:00.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":2842,"price":38.96,"value":110724.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.82 - $39.15 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":180597,"source":{"system":"sec-edgar","filing":"0001764013-26-000073","document":"wk-form4_1782517498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000073/wk-form4_1782517498.xml","form_type":"4"}},{"id":725543,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:45:00.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":14982,"price":38.19,"value":572162.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.75 - $38.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":183439,"source":{"system":"sec-edgar","filing":"0001764013-26-000073","document":"wk-form4_1782517498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000073/wk-form4_1782517498.xml","form_type":"4"}},{"id":725542,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:45:00.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":true,"shares":17824,"price":15.2,"value":270924.8,"ownership":{"direct":true},"balance_after":198421,"source":{"system":"sec-edgar","filing":"0001764013-26-000073","document":"wk-form4_1782517498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000073/wk-form4_1782517498.xml","form_type":"4"}},{"id":730538,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:02:25.000Z","date":"2026-06-18","kind":"sale","planned":false,"acquired":false,"shares":2634,"price":35.39,"value":93217.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on December 18, 2024, of which 6,872 of these RSUs vested on\nJune 16, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The\nsale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."}],"balance_after":180597,"source":{"system":"sec-edgar","filing":"0001779707-26-000006","document":"wk-form4_1782158542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000177970726000006/wk-form4_1782158542.xml","form_type":"4"}},{"id":810467,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-04-10T20:05:33.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":5165,"price":24.83,"value":128246.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 50,787 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 12,696 of these RSUs vested on\nApril 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The\nsale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":183231,"source":{"system":"sec-edgar","filing":"0001779707-26-000004","document":"wk-form4_1775851530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000177970726000004/wk-form4_1775851530.xml","form_type":"4"}},{"id":811514,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-09T20:17:27.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":59820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":59820,"derivative":{"exercise_price":24.61,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":59820},"source":{"system":"sec-edgar","filing":"0001764013-26-000036","document":"wk-form4_1775765844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000036/wk-form4_1775765844.xml","form_type":"4"}},{"id":811513,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-04-09T20:17:27.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":41343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":188396,"source":{"system":"sec-edgar","filing":"0001764013-26-000036","document":"wk-form4_1775765844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000036/wk-form4_1775765844.xml","form_type":"4"}},{"id":832396,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:11:19.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":2877,"price":24.97,"value":71838.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on December 18, 2024, of which 6,872 of these RSUs vested on\nMarch 16, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs.\nThe sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."}],"balance_after":147053,"source":{"system":"sec-edgar","filing":"0001764013-26-000015","document":"wk-form4_1774037475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000015/wk-form4_1774037475.xml","form_type":"4"}},{"id":962066,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:05:25.000Z","date":"2025-12-18","kind":"sale","planned":false,"acquired":false,"shares":2284,"price":27.38,"value":62535.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on December 18, 2024, of which 27,489 of these RSUs vested on December 16, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.25 - $27.52 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":149930,"source":{"system":"sec-edgar","filing":"0001764013-25-000163","document":"wk-form4_1766178313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000163/wk-form4_1766178313.xml","form_type":"4"}},{"id":962065,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:05:25.000Z","date":"2025-12-18","kind":"sale","planned":false,"acquired":false,"shares":8529,"price":26.78,"value":228406.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2024, the holder was granted 109,956 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on December 18, 2024, of which 27,489 of these RSUs vested on December 16, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.23 - $27.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":152214,"source":{"system":"sec-edgar","filing":"0001764013-25-000163","document":"wk-form4_1766178313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000163/wk-form4_1766178313.xml","form_type":"4"}},{"id":1179767,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T20:55:01.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":71531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest as to 25% of the shares on April 1, 2026 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":71531,"derivative":{"exercise_price":15.2,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":71531},"source":{"system":"sec-edgar","filing":"0001764013-25-000059","document":"wk-form4_1743713694.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000059/wk-form4_1743713694.xml","form_type":"4"}},{"id":1179766,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-04-03T20:55:01.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":50787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 1, 2026, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":160743,"source":{"system":"sec-edgar","filing":"0001764013-25-000059","document":"wk-form4_1743713694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000059/wk-form4_1743713694.xml","form_type":"4"}},{"id":1326800,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-18T22:02:50.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":137446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted pursuant to the Issuer's 2019 Equity Incentive Plan. The shares underlying the option will vest as to 25% of the shares on December 16, 2025, and the remainder will vest in 12 successive substantially equal quarterly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":137446,"derivative":{"exercise_price":27.63,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":137446},"source":{"system":"sec-edgar","filing":"0001764013-24-000204","document":"wk-form4_1734559363.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000204/wk-form4_1734559363.xml","form_type":"4"}},{"id":1326799,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":30999,"kind":"person","name":"Van Tuyl Christopher","position":1,"cik":"0001779707","reported_name":"Van Tuyl Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-12-18T22:02:50.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":109956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on December 16, 2025, and the remainder will vest in 12 successive substantially equal quarterly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":109956,"source":{"system":"sec-edgar","filing":"0001764013-24-000204","document":"wk-form4_1734559363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000204/wk-form4_1734559363.xml","form_type":"4"}}]}